30
Medications in Pregnancy Dr Cate Price 14 March 2015

Medications in Pregnancy Dr Cate Price 14 March 2015

Embed Size (px)

Citation preview

Page 1: Medications in Pregnancy Dr Cate Price 14 March 2015

Medications in Pregnancy

Dr Cate Price14 March 2015

Page 2: Medications in Pregnancy Dr Cate Price 14 March 2015

Dr Cate Price

• GP – Flagstaff Hill Medical Centre

• Medical Advisor – Obstetric shared care

• Medical Educator – Sturt Fleurieu

• VMO – WCH antenatal OPD

Page 3: Medications in Pregnancy Dr Cate Price 14 March 2015

Learning Objectives

• To have an understanding of safety categories for medications in pregnancy

• To know when and where to seek advice regarding safety of medications in pregnancy

• To learn examples of some “drugs of choice” for common conditions during pregnancy

Page 4: Medications in Pregnancy Dr Cate Price 14 March 2015

Medications in Pregnancy

• General perception that any drug exposures during pregnancy pose a potential risk to the fetus

• An Australian study showed that about 96% of women use some form of prescribed or non prescribed medication during pregnancy

Page 5: Medications in Pregnancy Dr Cate Price 14 March 2015

Teratogens• Teratogens are environmental agents introduced

during pregnancy that interfere with development such that they induce or increase the incidence of a congenital (structural) malformation.

• Drugs• Infections – Rubella, CMV• Chemicals – Mercury• Radiation• Behavioural teratogens – Alcohol, Valproic acid• Behavioural and Structural – Rubella, Isotretinion

Page 6: Medications in Pregnancy Dr Cate Price 14 March 2015

Teratogens

• Drugs to be avoided during pregnancy

• Isotretinoin – craniofacial, ear, cardiovascular and limb defects as well as structural CNS anomalies and neurodevelopmental problems

• Valproic acid – fetal valproate syndrome –facial dysmorphism and malformations including neural tube defects, cleft palate and cardiac anomalies as well as neurodevelopmental problems, can occur in > 10% of exposed infants

• Warfarin – use between 6-12 weeks –nasal hypoplasia and stippled epiphyses. Use in later pregnancy – fetal CNS haemorrhage

Page 7: Medications in Pregnancy Dr Cate Price 14 March 2015

Timing of exposure

• “All or none period” – first two weeks after conception or 2-4 weeks amenorrhoea from LMP

• Generally believed that exposures during this time do not cause malformations

• The conceptus is a mass of dividing stem cells with minimal contact with the maternal circulation and which have not yet differentiated into organs

Page 8: Medications in Pregnancy Dr Cate Price 14 March 2015

Timing of exposure• Embryonic period

• 4-11 weeks amenorrhoea• most critical period of development• structural defects – NTD, cardiac, orofacial• (Thalidomide caused limb defects after exposure

tween 20-35 days post conception)

Page 9: Medications in Pregnancy Dr Cate Price 14 March 2015

Timing of exposure• Fetal period

• Exposure does not cause malformations• May cause disruption of normally formed organs• (NSAIDs, ACEI – impair fetal renal function –

decrease fetal renal production and amniotic fluid volume – fetal joint contractures and pulmonary hypoplasia as a result of oligohydramnios)

Page 10: Medications in Pregnancy Dr Cate Price 14 March 2015

Australian Categorisation system for prescribing drugs

in Pregnancy

• https://www.tg.org.au/etg_demo/desktop/tgc/plg/5a57ea5.htm#categorya

Page 11: Medications in Pregnancy Dr Cate Price 14 March 2015

Categories• Incorrectly imply gradations of risk – B3 is not

necessarily safer than C• Do not take into account different stages of

pregnancy• Often assigned on the basis of animal studies• Assigned before release of drugs and often do not

change despite new evidence

Page 12: Medications in Pregnancy Dr Cate Price 14 March 2015

Information sources• Women’s and Children’s Hospital Drug

Information in Pregnancy and Breastfeeding• 8161 7222

• http://www.mothertobaby.org/otis-fact-sheets-s13037

Page 13: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• Ms C, age 36, is currently 9 weeks pregnant

• She has asthma for which she uses

• Fluticosone - Salmeterol 1 puff bd• Salbutamol prn

• How would you advise her about her medications?

Page 14: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• When her pregnancy was confirmed (at 5 weeks)

her GP advised her to cease the seretide and to use ventolin as needed.

• Do you agree with this advice?

Page 15: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• At 6 weeks pregnant she had an URTI and needed

to use her salbutamol several times a day• She saw another GP who advised her she could

use a preventer, but to use Budesonide rather than Fluticosone as this was a category A rather than a B3

• Is this reasonable advice?

Page 16: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• She feels her asthma is better controlled with the

Seretide than the Budesonide and she is still needing to use her salbutamol several times a day.

• How do you advise her?

Page 17: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• Discussion points

• The most common potentially serious medical problem that can affect pregnant women

• 1/3 can expect a worsening of their symptoms• Less likelihood of severe asthma during pregnancy if

the condition is well controlled when she conceives• All women who are are pregnant or planning a

pregnancy should be advised of the importance of continuing to use the asthma medication that best controls their asthma

Page 18: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• Discussion points

• Most asthma medications are inhaled – only small amounts of the drug enter the blood – cross the placenta

• It is far better to treat asthma aggressively with inhaled preventers to avoid the need for oral corticosteroids

Page 19: Medications in Pregnancy Dr Cate Price 14 March 2015

Asthma in Pregnancy• She is happy to resume Seretide.

• Later that afternoon, she rings and is worried as she has read the CMI leaflet in the medication box and it says to avoid this medication in pregnancy.

• How do you advise her?

Page 20: Medications in Pregnancy Dr Cate Price 14 March 2015

Hypertension in Pregnancy

• Ms P age 40 comes to you for pre natal counselling

• She was diagnosed with Hypertension 5 years ago and her BP is well controlled on Perindopril 5 mgs

• What do you advise her about her medication?

Page 21: Medications in Pregnancy Dr Cate Price 14 March 2015

Hypertension in pregnancy

• You seem to remember that ACE inhibitors are contraindicated during pregnancy.

• Where would you get accurate, up to date advice?

Page 22: Medications in Pregnancy Dr Cate Price 14 March 2015

Hypertension in Pregnancy

Some commonly prescribed anti hypertensive drugs are contraindicated or best avoided before conception and during pregnancyNone have been shown to be teratogenic.ACE inhibitors Angiotensin receptor blockersDiureticsBeta blockersCa channel antagonists

Page 23: Medications in Pregnancy Dr Cate Price 14 March 2015

Hypertension in Pregnancy

• ACE inhibitors are not recommended in the second and third trimesters of pregnancy

• Methyldpoa is the drug of choice

Page 24: Medications in Pregnancy Dr Cate Price 14 March 2015

Herbal Medication in Pregnancy

• Mary is pregnant with her first child.• She is currently 30 weeks pregnant and you have

seen her for shared care• The pregnancy has been uneventful• She asks you about raspberry leaf tea as she has

heard about it on Mumsnet

• What do you know about Raspberry Leaf Tea?

Page 25: Medications in Pregnancy Dr Cate Price 14 March 2015

Herbal Medication in Pregnancy

• Herbalists have long believed that raspberry leaf tea taken regularly during pregnancy can prevent complications and make delivery easier.

• Only one clinical study – no benefit• Did not significantly shorten labour, reduce pain

or prevent complications

Page 26: Medications in Pregnancy Dr Cate Price 14 March 2015

Herbal Medications• Medications considered safe

• Ginger• Echinacea• Evening Primrose oil• Valerian• Magnesium• Fish oil• Herbal teas

Page 27: Medications in Pregnancy Dr Cate Price 14 March 2015

Herbal Medications• Medications to be avoided – usually because of theoretical

uterine stimulation

• Aloe vera • Dong quai/Angelica• Feverfew • Arbor vitae• Goldenseal • Black and Blue Cohosh• Passionflower • Cascara• Pennyroyal• Comfrey • Pokeweed • Slippery Elm

Page 28: Medications in Pregnancy Dr Cate Price 14 March 2015

Drugs of ChoiceCondition Drug of Choice Other suitable

agentsComment

Allergic Rhinitis

Topical agentsNa cromoglycateCorticosteroidsSystemic antihistaminesPheniramineLoratidineCetrizine

PhenylephrineOxymetazolineXylometazoline

Topical decongestants – theoretical concerns about vasoconstriction

Cough/Cold ParacetamolThroat lozengesCodeineDextromethorphan

PseudoephedrinePhenyephrine

Pseudoephedrine/Phenylephrine -available in many cough/cold preparations - theoretical concerns about vasoconstriction

Page 29: Medications in Pregnancy Dr Cate Price 14 March 2015

Drugs of ChoiceConstipation Dietary

fibreDocusateBisacodylPsylliumParaffin

Lactulose Lactose should be avoided in people with lactose intolerance and Diabetes

Depression SSRIsSNRIsTCA

Mirtazepine

Conflicting data regarding possible increase risk of cardiovascular defects in babies exposed to SSRIs. Reassuring long term neurodevelopmental data

Diarrhoea Codeine Loperamide

Fever Paracetamol

NSAIDs NSAIDs should be avoided in the third trimester because of fetal renal side effects and the potential to cause premature closure of the ductus arteriosus

Page 30: Medications in Pregnancy Dr Cate Price 14 March 2015

Drugs of ChoiceNausea and vomiting of pregnancy

GingerVitamin B6Doxylamine

MetoclopramideOndansetron

Heartburn/Reflux

AntacidsSimetheconeH2

antagonists

Omeprazole and other PPIs

Recent studies have shown that omeprazole is not associated with any increase risk of birth defects or other adverse pregnancy outcomes

Pain ParacetamolCodeineMorphinePethidine

NSAIDs NSAIDs should be avoided in the third trimester because of fetal renal side effects and the potential to cause premature closure of the ductus arteriosus